Specificity of RGS10A as a key component in the RANKL signaling mechanism for osteoclast differentiation - Wikidata - wikimedia - TriplyDB

Specificity of RGS10A as a key component in the RANKL signaling mechanism for osteoclast differentiation

Specificity of RGS10A as a key component in the RANKL signaling mechanism for osteoclast differentiation

http://www.wikidata.org/entity/Q33299652

about

Cellular deficiency in the RGS10 protein facilitates chemoresistant ovarian cancer Downregulation of both gene expression and activity of Hsp27 improved maturation of mouse oocyte in vitro RNAi-mediated silencing of Atp6i and Atp6i haploinsufficiency prevents both bone loss and inflammation in a mouse model of periodontal disease Atp6v0d2 is an essential component of the osteoclast-specific proton pump that mediates extracellular acidification in bone resorption.Targeting Atp6v1c1 Prevents Inflammation and Bone Erosion Caused by Periodontitis and Reveals Its Critical Function in Osteoimmunology Signaling networks that control the lineage commitment and differentiation of bone cells.Ac45 silencing mediated by AAV-sh-Ac45-RNAi prevents both bone loss and inflammation caused by periodontitis.Collagen XXIV (Col24α1) promotes osteoblastic differentiation and mineralization through TGF-β/Smads signaling pathway.IL-1R/TLR2 through MyD88 Divergently Modulates Osteoclastogenesis through Regulation of Nuclear Factor of Activated T Cells c1 (NFATc1) and B Lymphocyte-induced Maturation Protein-1 (Blimp1).Functions of RANKL/RANK/OPG in bone modeling and remodeling.Role of Regulators of G Protein Signaling Proteins in Bone Physiology and Pathophysiology.RNA interference-mediated silencing of Atp6i prevents both periapical bone erosion and inflammation in the mouse model of endodontic disease Atp6v1c1 may regulate filament actin arrangement in breast cancer cells.Role of regulator of G protein signaling proteins in bone.Inhibition of Rgs10 Expression Prevents Immune Cell Infiltration in Bacteria-induced Inflammatory Lesions and Osteoclast-mediated Bone Destruction.Alveolar bone loss: mechanisms, potential therapeutic targets, and interventions.Galactosemia, a single gene disorder with epigenetic consequences.Osteoclast proton pump regulator Atp6v1c1 enhances breast cancer growth by activating the mTORC1 pathway and bone metastasis by increasing V-ATPase activity.Atp6v1c1 is an essential component of the osteoclast proton pump and in F-actin ring formation in osteoclasts.MSRA polymorphism is associated with the risk of rheumatoid arthritis in a Chinese population.

P2860

Q26796258-8FD9BC73-0EF9-4D7C-8985-BB4104D38824 Q33933900-989C8BEA-F6C1-4B5C-817E-6FBB3B8AD2FD Q34663536-9E151362-B53E-418A-B91D-92C1CEED7057 Q34911875-209C976B-B054-438A-8405-5A1C75144AA9 Q35746167-93C7E8B9-0964-4C0C-8B58-F2690739B051 Q36082866-94199063-98A3-4415-AEF9-3935AB40936D Q36207488-AC74E63B-3C16-47B6-8496-55CB7062D38B Q36382310-4FEF4335-D638-45E3-857C-14715D622261 Q36444288-63CE3E30-662B-4016-A500-7C6451066AA9 Q36700779-0046EA2E-487A-43F9-99FF-9B4ACEE88938 Q36756644-DD901DF0-E128-410B-9F62-B85582553E80 Q36804730-1A618C90-E669-4F7E-B8C5-DC1553FDF848 Q37483783-1C253FA2-ACEE-453D-ACF7-AA59FE156706 Q37665104-D9052075-4744-4EEB-BC4D-B56ABA926B0D Q37714447-9AF159F0-BD35-4522-8A46-1FFAA15DBB60 Q38204892-D6E7B287-B944-4430-9F33-203AE9429A0A Q38348448-EB1B376E-CCE4-4424-A13A-E6A5E1F485A1 Q38703517-5BE21FB0-904B-4F35-81FD-35AF5B304109 Q42043704-2C6C81B9-5AE8-4B90-A348-2CA2AC511F12 Q46469299-E5416E15-77C7-4CA2-A746-F13609299231

P2860

Specificity of RGS10A as a key component in the RANKL signaling mechanism for osteoclast differentiation

http://www.wikidata.org/entity/Q33299652

description

2007 nî lūn-bûn

@nan

2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Specificity of RGS10A as a key ...... for osteoclast differentiation

@ast

Specificity of RGS10A as a key ...... for osteoclast differentiation

@en

Specificity of RGS10A as a key ...... or osteoclast differentiation.

@nl

type

label

Specificity of RGS10A as a key ...... for osteoclast differentiation

@ast

Specificity of RGS10A as a key ...... for osteoclast differentiation

@en

Specificity of RGS10A as a key ...... or osteoclast differentiation.

@nl

prefLabel

Specificity of RGS10A as a key ...... for osteoclast differentiation

@ast

Specificity of RGS10A as a key ...... for osteoclast differentiation

@en

Specificity of RGS10A as a key ...... or osteoclast differentiation.

@nl

P1433

Q33299652-FDE8A553-4ACA-464D-AA1D-0F90BED95EEA

P1476

Q33299652-7000E4F6-A60E-4E6F-B0FD-8D85B4EBA40E

P2093

Q33299652-1B43698A-2420-456A-9B1C-297C554CA277

Q33299652-8F95BB3D-98BA-444B-BFDE-FE9CEF304742

Q33299652-B7D9DFDD-C8E4-47D3-A433-08BE8E224C77

Q33299652-F926E797-7B93-4999-ACD7-1B8988C3179E

P2860

Q33299652-01A32C8F-4202-4518-8BD4-7F7D4FD90841

Q33299652-0E542439-1603-4E70-B122-AB6CEB165CEB

Q33299652-105FD440-6FCB-4984-A2C6-265EAD9DB03F

Q33299652-12F5D455-D5AD-49C2-8F7B-3D4BB8A1143D

Q33299652-1E6FADC1-3244-4C63-BCEE-22A3DFC175F3

Q33299652-22454601-B242-41F5-A7AC-6650CA6282C8

Q33299652-29280C6B-1497-42C0-8798-001C423E94E1

Q33299652-3CAD4DEF-4468-45AB-B76F-FC2D231379A3

Q33299652-431E636F-5471-4918-ACBC-38282F81F9E0

Q33299652-4342980E-B2C7-4CB0-987E-ACDA1EFC4900

P304

Q33299652-E53597F0-9FC6-49C1-8B54-0D25A2DC5EB7

P31

Q33299652-1AEFA75D-13F8-46AE-AC6C-84152F8FECBB

P356

Q33299652-8B4D9206-7D97-448E-814F-0544FFFD07B6

P407

Q33299652-2422E12E-D425-4BC9-889A-D6A76DB74DA7

P433

Q33299652-D0359A6B-380C-4B71-9EDE-D2F85A3A9DD9

P478

Q33299652-031549DF-E7B0-42D9-981D-FFB2BC1AF046

P577

Q33299652-0BCF8EE2-0407-4556-97E3-CCA74344EEB8

P5875

Q33299652-F7C4D227-4957-4F38-97A1-FD282929F137

P698

Q33299652-FD0A2FDA-D9AE-496A-9B6B-0584BECACD4A

P932

Q33299652-3D9336B5-8274-4C70-AE05-8551BA6A291F

P356

P1433

Journal of Cell Science

P1476

Specificity of RGS10A as a key ...... for osteoclast differentiation

@en

P2093

Philip Stashenko

http://www.w3.org/2001/XMLSchema#string

Shuying Yang

http://www.w3.org/2001/XMLSchema#string

Wei Chen

http://www.w3.org/2001/XMLSchema#string

Yi-Ping Li

http://www.w3.org/2001/XMLSchema#string

P2860

Bcl-2 regulator FKBP38 is activated by Ca2+/calmodulin.

RGS12 is essential for RANKL-evoked signaling for terminal differentiation of osteoclasts in vitro

Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice

Characterization of RGS5 in regulation of G protein-coupled receptor signaling

NFAT signaling: choreographing the social lives of cells

Cloning and complete coding sequence of a novel human cathepsin expressed in giant cells of osteoclastomas

Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes

Osteoclast differentiation and activation

Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts

RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells

P304

3362-3371

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1242/JCS.008300

http://www.w3.org/2001/XMLSchema#string

P407

P433

Pt 19

http://www.w3.org/2001/XMLSchema#string

P478

120

http://www.w3.org/2001/XMLSchema#string

P577

2007-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5960665

http://www.w3.org/2001/XMLSchema#string

P698

17881498

http://www.w3.org/2001/XMLSchema#string

P932

3587975

http://www.w3.org/2001/XMLSchema#string